Labcorp Holdings (LH) Cost of Revenue (2009 - 2026)

Labcorp Holdings has disclosed Cost of Revenue across 18 years of filings, most recently posting $2.5 billion for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $2.5 billion, up 5.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.1 billion (up 5.93% YoY), and the FY2025 annual result was $9.9 billion, up 5.91% from the prior year.
• Cost of Revenue came in at $2.5 billion for Q1 2026 at Labcorp Holdings, roughly flat from $2.5 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $2.7 billion in Q1 2022 to a low of $2.0 billion in Q2 2022.
• The 5-year median for Cost of Revenue is $2.3 billion (2024), against an average of $2.3 billion.
• Peak annual rise in Cost of Revenue reached 549.48% in 2022, while the deepest fall reached 26.02% in 2022.
• Labcorp Holdings' Cost of Revenue stood at $2.1 billion in 2022, then gained by 3.77% to $2.2 billion in 2023, then grew by 10.0% to $2.4 billion in 2024, then gained by 3.68% to $2.5 billion in 2025, then increased by 0.05% to $2.5 billion in 2026.
• The last three Cost of Revenue figures came in at $2.5 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.5 billion (Q3 2025), per Business Quant data.